Persistent musculoskeletal presentations post-chikungunya fever: a case series in a state in northeast Brazil

Authors

DOI:

https://doi.org/10.33448/rsd-v11i3.26915

Keywords:

Arbovirosis; Arthralgia; Chikungunya fever.

Abstract

Chikungunya fever (CF) is an arbovirosis caused by the Chikungunya virus (CHIKV). The main characteristic of CF is joint pain and more than half of infected patients experience chronic conditions. This case series study evaluated the persistent musculoskeletal presentations of CF in a sample of 72 patients with persistent symptoms (≥1 month) after CF confirmed by laboratory tests (detection of CHIKV by polymerase chain reaction [PCR] and/or immunoglobulin [Ig]M and/or IgG). The patients were followed up for 12 months after treatment at the outpatient clinic of the University Hospital of the Federal University of Sergipe (Hospital Universitário da Universidade Federal de Sergipe - HU/UFS). They were evaluated at admission and after 1 month, 2 months, and then every 3 months for up to 12 months. Painful and/or swollen joints, periarticular symptoms, other important findings on physical examination, and visual analogue pain scale (VAS) were evaluated during all consultations. Main results: Among the patients evaluated, 84.7% were female, the mean age was 53.8 years, and the mean duration of musculoskeletal complaints was 6 months. Comorbidities were present in 61.1% of patients and previous musculoskeletal disease was present in 69.4%. The most frequent presentation on admission was polyarticular, which occurred in 76.4% of cases. The most affected joints were the hands, knees, ankles, and feet. VAS on admission was intense in 66.7% of patients. Tenosynovitis was present in 44.5% of patients and was more frequently reported in the ankles. Corticosteroids and chloroquine were administered to 65.3% and 31.98% of patients, respectively. The findings indicated that persistent musculoskeletal presentations occur frequently after CF. These results provide a better understanding of patient profiles, musculoskeletal involvement, and CF progression, and may guide effective strategies for therapeutic management.

Author Biographies

Alejandra Debbo, Federal University of Sergipe

Rheumatologist doctor

Weber de Santana Teles, Sergipe Hemotherapy Center (HEMOSIS)

Doctor in health and environment

Ruth Cristini Torres, Sergipe Institute of Hematology and Hemotherapy (IHHS)

PhD in health and environment

Ângela Maria Melo Sá Barros, Federal University of Rio de Janeiro

Master/PhD student in Nursing

Max Cruz da Silva, College Pio Décimo of Canindé de São Francisco

Academic in nursing

Maria Hozana Santos Silva, AGES Faculty of Medicine

Interdisciplinary Master in Health and Environment

References

Amaral, J. K., Bilsborrow, J. B., & Schoen, R. T. (2019). Brief report: the disability of chronic chikungunya arthritis. Clin Rheumatol, 38(7), 2011-2014.

Amaral, J. K., Bilsborrow, J. B., & Schoen, R. T. (2020). Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common. Am J Med, 133(3).

Arroyo, M. A., & Vilá, M. L. (2015). Rheumatic manifestations in patients with chikungunya infection. PRHSJ, 34(2), 71- 77.

Benjamanukul, S., Osiri, M., Chansaenroj, J., Chirathaworn, C., & Poovorawan Y. (2021). Rheumatic manifestations of Chikungunya virus infection: Prevalence, patterns, and enthesitis. PLoS One, 16(4), 1-15.

Brasil. (2015). Ministério da Saúde. Febre chikungunya: manejo clínico. 1ª edição. Brasília: Ministério da Saúde. http://bvsms.saude.gov.br/bvs/publicacoes/febre_chikungunya_manejo_clinico.pdf.

Brasil. (2017). Ministério da Saúde. Boletim Epidemiológico: Monitoramento dos casos de dengue, febre de chikungunya e febre pelo vírus Zika até a Semana Epidemiológica, (48)3, 1-11.

Brasil. (2020). Ministério da Saúde. Boletim Epidemiológico 51. Monitoramento dos casos de arboviroses urbanas transmitidas pelo Aedes Aegypti (dengue, chikungunya e zika), semanas epidemiológicas 1 a 50, 2020. 51(51), 1-33.

Brito, C. A. A., Sohsten, A. K. A. V., Leitão, C. C. S., Brito, R. C. C. M., Valadares, L. D. A., & Fonte, C. A. M. (2016). Pharmacologic management of pain in patients with Chikungunya: a guideline. Rev Soc Bras Med Trop, 49(6), 668-679.

Cunha, R. V., & Trinta, K. S. (2017). Chikungunya virus: clinical aspects and treatment - A Review. Mem. Inst. Oswaldo Cruz, 112(8), 523-531.

Donalisio, M. R., Freitas, A. R. R. (2015). Chikungunya in Brazil: an emerging challenge. Rev Bras Epidemiol, 18(1), 283-285.

Essackjee, K., Goorah, S., Ramchurn, S. K., & Cheeneebash, J. (2013). Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad Med J, 89(2), 440-447.

Hibl, B. M., Dailey, N. J. M., Kneubehl, A. R., Vogt, M. B., & Spencer, J. L. (2021). Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis, 15(6), 1-35.

Hua, C., & Combe, B. (2017). Chikungunya Virus-Associated Disease. Current Rheumatology Reports, 19(69), 1-7.

Huits, R., Kort, J., Van, D. R., Chong, L., & Tsoumanis, A. (2018). Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia. Plos One, 13(4), 1-21.

Javelle, E., Ribera, A., Degasne, I., & Gaüzère, B. A. (2015). Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. PLOS Negl Trop Dis, 9(3), 1-18.

Marques, C. D. L., Duarte, A. L. B. P., & Ranzolin, A. (2017). Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2 - Treatment. Rev Bras Reumatol, 57(2), 438-451.

Neves, E. L. A., & Nunes, P. S. (2018). Carpal tunnel syndrome observed after an arbovirus infection: A preliminary case series report. NeurologicalSci, 12(2), 31-33.

Nisar, M. K., Packianathan, C. (2017). Chikungunya and bilateral sacroiliitis – is there a link? Eur J Rheumatol, 4(1), 81-82.

Oliveira, A. S., & Silva, J. G. (2017). Effect of a physiotherapy program in patient with persistente polyarthralgia after chikungunya fever. Case report. Rev Dor, 18(4), 370-3.

Page, P. (2012). Current concepts in muscle stretching for exercise and rehabilitation. Int J Sports Phys Ther, 7(2), 109-119.

Runowska, M., Majewski, D., Niklas, K., & Puszczewicz, M. (2018). Chikungunya virus: a rheumatologist's perspective. Clinical and Experimental Rheumatology, 36(3), 494-501.

Silva, N. M., et al. (2018). Vigilância de chikungunya no Brasil: desafios no contexto da Saúde Pública. Epidemiol. Serv. Saúde, 27(3), 1-19.

Simon, F., Javelle, E., Cabie, A., Bouquillard, E., & Troisgros. (2015). French guidelines for the management of Chikungunya (acute and persistent presentations). Med Mal Infect, 45(2), 243-263.

Vairo, F., Haider, N., Kock, R., & Ntoumi, F. (2019). Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. Infect Dis Clin North Am, 33(4), 1003-1025.

Vu, D. M., Jungkind, D., & Labeaud, A.D. (2017). Chikungunya Virus. Clin Lab Med, 37(2), 371–382.

Weaver, C. S., & Lecuit, M. (2015). Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease. NEJM, 372(13), 1231-1239.

Zaid, A., Gérardin, P., Taylor, A., Mostafavi, H., Malvy, D., & Mahalingam S. (2018). Chikungunya Arthritis: Implications of Acute and Chronic Inflammation Mechanisms on Disease Management. Arthritis Rheumatol, 70(4), 484-495.

Downloads

Published

07/03/2022

How to Cite

DEBBO, A.; CARVALHO, V. F. A. .; SILVA, Ângela M. da .; PACHECO, R. de A. .; SILVA, J. R. S. .; TELES, W. de S. .; TORRES, R. C. .; BARROS, Ângela M. M. S. .; SILVA, M. C. da .; SILVA, M. H. S. . Persistent musculoskeletal presentations post-chikungunya fever: a case series in a state in northeast Brazil. Research, Society and Development, [S. l.], v. 11, n. 3, p. e56011326915, 2022. DOI: 10.33448/rsd-v11i3.26915. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/26915. Acesso em: 14 nov. 2024.

Issue

Section

Health Sciences